During The PSYCH Symposium in November 2020, Professor David Nutt, chairman of Awakn Life Sciences, founder of Drug Science and the director of neuropsychopharmacology at Imperial College London, delivered a virtual keynote speech on ...
A new company straddling both the functional health and psychedelic space with a consumer/retail first approach. Backed by a leading team of scientists, doctors, investors and experts across the wellness space, the company has full ...
Exclusive: Saint Vincent and the Grenadines announces initiative to permit psychedelic treatment and research The Caribbean nation of Saint Vincent and the Grenadines has launched an initiative to permit and support psychedelic ...
For the first time, stock in a psychedelic medicine company was traded on the market – and it was major success. Compass Pathways (NASDAQ: CMPS) went public by launching its IPO earlier this months and sold 7.5 million shares, ...
Field Trip Health Ltd. (CSE: FTRP) began trading shares on the Canadian Securities Exchange on Tuesday 6th October, opening at $3.50 Canadian Dollars and closing its first day at $2.70 Canadian Dollars. The public listing comes on the ...
While a number of states have begun to legalise the medical use of certain psychedelics, widespread legalisation is set to start taking place from 2021 onwards. The new global psychedelics industry will be poised to result in cost ...
This is a nascent and fast emerging industry, witnessing a flurry of commercial activity, including the founding of new companies, a number of IPO listings from established companies and a spate of M&A activity occurring on an ...
PSYCH by Prohibition Partners conducts proprietary research on consumer attitudes to psychedelics In May 2020, Prohibition Partners conducted a nationally representative consumer survey in the US and the UK, the aim of which was to ...
COVID-19 and the ‘new normal’ for healthcare provision Pioneers and early movers in the psychedelics industry are using tech to a) develop bespoke therapies for patients which are individually tailored to treat their specific mental ...
